Oxford Genetics, a synthetic biology-based technologies for biologics discovery, development and delivery specialist, has announced the appointment of its new COO, Jocelyne Bath. She fills a new role within the executive team.
Ms Bath has an extensive background working in businesses from science and engineering technology sectors. Prior to joining Oxford Genetics she was Chief Revenue Officer at EYOTO, providers of cutting edge eye care technology and before that VP-Commercial Strategy for P2i, global leaders in liquid repellent nano-coating technology.
Her early career was spent with Orange Business Services. She has comprehensive experience in product, revenue and commercial management, with early roles in product pricing and analysis leading to strategic commercial management later in her career and more recently, executive level roles.
At Oxford Genetics Ms Bath will be responsible for commercial positioning and business operations.
“Oxfordshire is a fantastic centre for science and technology, I’m delighted to be part of the Oxford Genetics team and looking forward to the journey ahead. I’ve joined at an exciting time, with innovative solutions, a strong team and sound backing, Oxford Genetics has a bright future,” said Ms Bath.
Oxford Genetics has gone from strength to strength over the past 18 months, signing supply and license agreements with key customers, opening offices in the US and strategically adding new and innovative solutions to its portfolio.
